Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Meltz Mark A

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-12-01
Tax Withholding
2022-12-02
8:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
541$7.7527,924
(Direct)
View
2022-09-01
Option Award
2022-09-02
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
25,000$028,465
(Direct)
View
2022-02-11
Option Award
2022-02-15
4:01 pm
N/A
2032-02-11
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Treasurer
135,000$0135,000
(Direct)
View
2021-02-12
Option Award
2021-02-16
6:00 pm
N/A
2031-02-12
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Treasurer
100,000$0100,000
(Direct)
View
2020-12-02
Ownership
2020-12-02
9:12 pm
2020-04-02
2030-04-02
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Treasurer
0$0506,011
(Direct)
View
2020-01-15
Equity Swap
2020-01-15
1:32 pm
N/A
N/A
Audentes Therapeutics Inc.BOLDMeltz Mark A
SVP General Counsel
32,705$600
(Direct)
View
2020-01-15
Disposition
2020-01-15
1:32 pm
N/A
2029-03-28
Audentes Therapeutics Inc.BOLDMeltz Mark A
SVP General Counsel
104,000$00
(Direct)
View
2019-12-12
Tax Withholding
2019-12-16
6:04 pm
N/A
N/A
Audentes Therapeutics Inc.BOLDMeltz Mark A
SVP General Counsel
4,628$59.3732,705
(Direct)
View
2019-03-28
Option Award
2019-04-01
5:54 pm
N/A
2029-03-28
Audentes Therapeutics Inc.BOLDMeltz Mark A
SVP General Counsel
141,333$0141,333
(Direct)
View
2019-03-28
Ownership
2019-04-01
5:53 pm
N/A
N/A
Audentes Therapeutics Inc.BOLDMeltz Mark A
SVP General Counsel
0$00
(Direct)
View